Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial von Hochhaus, A, Saglio, G, Hughes, T P, Larson, R A, Kim, D-W, Issaragrisil, S, le Coutre, P D, Etienne, G, Dorlhiac-Llacer, P E, Clark, R E, Flinn, I W, Nakamae, H, Donohue, B, Deng, W, Dalal, D, Menssen, H D, Kantarjian, H M

Volltext

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia von Cross, N C P, White, H E, Colomer, D, Ehrencrona, H, Foroni, L, Gottardi, E, Lange, T, Lion, T, Machova Polakova, K, Dulucq, S, Martinelli, G, Oppliger Leibundgut, E, Pallisgaard, N, Barbany, G, Sacha, T, Talmaci, R, Izzo, B, Saglio, G, Pane, F, Müller, M C, Hochhaus, A

Volltext

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia von Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., Hjorth-Hansen, H., Hughes, T. P., Janssen, J. J. W. M., Kantarjian, H. M., Kim, D. W., Larson, R. A., Lipton, J. H., Mahon, F. X., Mayer, J., Nicolini, F., Niederwieser, D., Pane, F., Radich, J. P., Rea, D., Richter, J., Rosti, G., Rousselot, P., Saglio, G., Saußele, S., Soverini, S., Steegmann, J. L., Turkina, A., Zaritskey, A., Hehlmann, R.

Volltext

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study von Hochhaus, A, Masszi, T, Giles, F J, Radich, J P, Ross, D M, Gómez Casares, M T, Hellmann, A, Stentoft, J, Conneally, E, García-Gutiérrez, V, Gattermann, N, Wiktor-Jedrzejczak, W, le Coutre, P D, Martino, B, Saussele, S, Menssen, H D, Deng, W, Krunic, N, Bedoucha, V, Saglio, G

Volltext

Standardized definitions of molecular response in chronic myeloid leukemia von Cross, N C P, White, H E, Müller, M C, Saglio, G, Hochhaus, A

Volltext

Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up von Larson, R A, Hochhaus, A, Hughes, T P, Clark, R E, Etienne, G, Kim, D-W, Flinn, I W, Kurokawa, M, Moiraghi, B, Yu, R, Blakesley, R E, Gallagher, N J, Saglio, G, Kantarjian, H M

Volltext

Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy: a re... von Giles, F J, Mauro, M J, Hong, F, Ortmann, C-E, McNeill, C, Woodman, R C, Hochhaus, A, le Coutre, P D, Saglio, G

Volltext

Harmonization of molecular monitoring of CML therapy in Europe von Müller, M C, Cross, N C P, Erben, P, Schenk, T, Hanfstein, B, Ernst, T, Hehlmann, R, Branford, S, Saglio, G, Hochhaus, A

Volltext

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale von Cross, N C P, White, H E, Ernst, T, Welden, L, Dietz, C, Saglio, G, Mahon, F-X, Wong, C C, Zheng, D, Wong, S, Wang, S-S, Akiki, S, Albano, F, Andrikovics, H, Anwar, J, Balatzenko, G, Bendit, I, Beveridge, J, Boeckx, N, Cerveira, N, Cheng, S-M, Colomer, D, Czurda, S, Daraio, F, Dulucq, S, Eggen, L, El Housni, H, Gerrard, G, Gniot, M, Izzo, B, Jacquin, D, Janssen, J J W M, Jeromin, S, Jurcek, T, Kim, D-W, Machova-Polakova, K, Martinez-Lopez, J, McBean, M, Mesanovic, S, Mitterbauer-Hohendanner, G, Mobtaker, H, Mozziconacci, M-J, Pajič, T, Pallisgaard, N, Panagiotidis, P, Press, R D, Qin, Y-Z, Radich, J, Sacha, T, Touloumenidou, T, Waits, P, Wilkinson, E, Zadro, R, Müller, M C, Hochhaus, A, Branford, S

Volltext

Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study von Giles, F J, le Coutre, P D, Pinilla-Ibarz, J, Larson, R A, Gattermann, N, Ottmann, O G, Hochhaus, A, Radich, J P, Saglio, G, Hughes, T P, Martinelli, G, Kim, D-W, Novick, S, Gillis, K, Fan, X, Cortes, J, Baccarani, M, Kantarjian, H M

Volltext

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study von Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M, Giles, F J

Volltext

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia von Santini, V, Allione, B, Zini, G, Gioia, D, Lunghi, M, Poloni, A, Cilloni, D, Sanna, A, Masiera, E, Ceccarelli, M, Abdel-Wahab, O, Terenzi, A, Angelucci, E, Finelli, C, Onida, F, Pelizzari, A, Ferrero, D, Saglio, G, Figueroa, M, Levis, A

Volltext

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in... von Gabert, J, Beillard, E, van der Velden, V H J, Bi, W, Grimwade, D, Pallisgaard, N, Barbany, G, Cazzaniga, G, Cayuela, J M, Cavé, H, Pane, F, Aerts, J L E, De Micheli, D, Thirion, X, Pradel, V, González, M, Viehmann, S, Malec, M, Saglio, G, van Dongen, J J M

Volltext

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib von Castagnetti, F, Gugliotta, G, Breccia, M, Stagno, F, Iurlo, A, Albano, F, Abruzzese, E, Martino, B, Levato, L, Intermesoli, T, Pregno, P, Rossi, G, Gherlinzoni, F, Leoni, P, Cavazzini, F, Venturi, C, Soverini, S, Testoni, N, Alimena, G, Cavo, M, Martinelli, G, Pane, F, Saglio, G, Rosti, G, Baccarani, M

Volltext

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study von Iurlo, A, Cattaneo, D, Consonni, D, Castagnetti, F, Miggiano, M C, Binotto, G, Bonifacio, M, Rege-Cambrin, G, Tiribelli, M, Lunghi, F, Gozzini, A, Pregno, P, Abruzzese, E, Capodanno, I, Bucelli, C, Pizzuti, M, Artuso, S, Iezza, M, Scalzulli, E, La Barba, G, Maggi, A, Russo, S, Elena, C, Scortechini, A R, Tafuri, A, Latagliata, R, Caocci, G, Bocchia, M, Galimberti, S, Luciano, L, Fava, C, Foà, R, Saglio, G, Rosti, G, Breccia, M

Volltext

BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP von Morotti, A, Panuzzo, C, Crivellaro, S, Pergolizzi, B, Familiari, U, Berger, A H, Saglio, G, Pandolfi, P P

Volltext

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reacti... von BEILLARD, E, PALLISGAARD, N, WATZINGER, F, LION, T, VAN DONGEN, J. J. M, HOKLAND, P, GABERT, J, VAN DER VELDEN, V. H. J, BI, W, DEE, R, VAN DER SCHOOT, E, DELABESSE, E, MACINTYRE, E, GOTTARDI, E, SAGLIO, G

Volltext

BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase von Hughes, T P, Saglio, G, Quintás-Cardama, A, Mauro, M J, Kim, D-W, Lipton, J H, Bradley-Garelik, M B, Ukropec, J, Hochhaus, A

Volltext

Differences among young adults, adults and elderly chronic myeloid leukemia patients von Gugliotta, G., Breccia, M., Specchia, G., Abruzzese, E., Iurlo, A., Martino, B., Pregno, P., Stagno, F., Cuneo, A., Bonifacio, M., Gobbi, M., Russo, D., Gozzini, A., Alimena, G., Pane, F., Rosti, G., Salvi, F., Pini, M., Leoni, P., Galieni, P., Bigazzi, C., Cantore, N., Palmieri, F., Albano, F., Russo Rossi, A., Rambaldi, A., Palandri, F., Testoni, N., Luatti, S., Soverini, S., Bochicchio, M.T., Apolinari, M., Cervello, I., Capucci, A., Malpignano, A., Girasoli, M., Usala, E., Sartori, R., Molica, S., Lanza, F., Viganò, C., Rapezzi, D., Bosi, A., Santini, V., Capalbo, S.F., Spinosa, G., Pierri, I., Carella, A.M., De Blasio, A., Ciccone, F., Russo, S., Morra, E., Pungolino, E.M., Luppi, M., Marasca, R., Gambacorti-Passerini, C., Ferrara, F., Latte, G., Noli, D., Rege-Cambrin, G., Fava, C., Semenzato, G., Turri, D., Siragusa, S., Aversa, F., Crugnola, M., Cazzola, M., Orlandi, E., Falini, B., Falzetti, F., Visani, G., Isidori, A., Fioritoni, G., Di Lorenzo, R., Vallisa, D., Galimberti, S., Pizzuti, M., Zaccaria, A., Salvucci, M., Ielo, D., Merli, F., Avanzini, P., Musto, P., De Stefano, V., De Fabritiis, P., Trawiska, M., Pacilli, L., Cedrone, M., Petti, M.C., Tafuri, A., Montefusco, E., Bocchia, M., Liberati, A.M., Luzzi, D., Boccadoro, M., Ferrero, D., Calistri, E., Meneghini, V., Rodighiero, F., D'Emilio, A.

Volltext

Altered Erythropoiesis in Mouse Models of Type 3 Hemochromatosis von Roetto, A., Saglio, Giuseppe G., Pollicino, P., Osella, L., Palmieri, A., Boero, M., Ferbo, L., Riondato, Fulvio, Pellegrino, R. M., Miniscalco, B.

Volltext